This project aims to accelerate translational research by characterizing pre-clinical models including the NF1-deficient and OPG-bearing Ossabaw pig and perform pilot studies designed to determine therapeutic efficacy of top neuroprotection, regeneration, and stem cell candidate treatments.
Investigators
Jeffrey Goldberg, MD, PhD
Stanford University
School of Medicine
Jeffrey Goldberg, MD, PhD
Stanford University
School of Medicine
Current Stage
Discovery
In Vivo Proof of Concept
IND Enabling
Clinical Trial Phase 1
Clinical Trial Phase 2
Clinical Trial Phase 3